Company: BNBX
Filing Date: 2025-12-30
Form Type: 424B3
Source: 0001104659-25-125037
Chunk: 3

Company: BNB PLUS CORP.
Filing Date: 2025-12-30
Form: 424B3
Chunk 3
---
 effective registration statement registering, or the prospectus contained therein is not available for,
the resale of the underlying shares of Common Stock by the holder thereof.

The closing of the Cash Private
Placement and the issuance and sale of the Placement Agent Warrants, Advisory Warrants and Consultant Warrants was consummated on October 3,
2025. The closing of the Crypto Private Placement was consummated on October 21, 2025.

The Selling Stockholders
and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby
on The Nasdaq Capital Market or any other stock exchange, market or trading facility on which the securities are traded or in private
transactions. These sales may be at fixed or negotiated prices. We will not receive any proceeds from the resale or other disposition
of such securities by the Selling Stockholders. However, we will receive the proceeds of any cash exercise of the Pre-Funded Warrants,
Series E Warrants, Placement Agent Warrants, Advisory Warrants and Consultant Warrants. See “Use of Proceeds” beginning
on page 16 and “Plan of Distribution” beginning on page 20 of this prospectus for more information.

Our Common Stock is listed
on The Nasdaq Capital Market under the symbol “BNBX.” The closing price of the Common Stock on December 29, 2025, as
reported by The Nasdaq Capital Market, was $2.20 per share.

We are a “smaller reporting
company,” as defined under the federal securities laws and, as such, have elected to comply with certain reduced reporting requirements
for this prospectus and may elect to do so in future filings. See the section titled “Implications of Being a Smaller Reporting
Company.”

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 13 of this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The securities are not being offered in any jurisdiction where the offer is not permitted.

<div align='center'>The date of this prospectus is December
30, 2025.

Table of Contents</div